• The Lothian Birth Cohorts of 1921Cohorts of (N = 550) and 1936Cohorts of (N = 1091 have cognitive test data from age 11 and old age and are used to examine the contributions to lifetime cognitive change and cognitive change within old age.
studies described here were initially set up to study determinants of non-pathological cognitive ageing; i.e., the ageing of cognitive functions largely in the normal range, and not principally dementia or other pathological cognitive disorders. 
What does it cover?
The LBC1921 and LBC1936 studies were set up to discover determinants, beginning with a genetic emphasis, of individual differences in cognitive changes from childhood to old age, and also within old age. However, the independent (predictor, exposure) and the dependent (outcome) variables were always much broader than genetic and cognitive, respectively. Putative determinants in both cohorts include demographic, social, psychological, medical, physiological, biomedical, and genetic factors. Outcomes of interest in both cohorts include cognitive, other psycho-social, and medical variables. Brain imaging variables-as outcomes, mediators and predictors-are a major focus of the LBC1936.
The original aim of the LBC1921 study was to seek "Molecular genetic influences on cognitive ageing in healthy old people," which was the title of the BBSRC grant that funded the wave 1 data collection. The objectives were: to test the effect of APOE e4 status on lifetime cognitive ageing; to collect social, cognitive, and medical data; and to retain the phenotypic information and DNA in order to test other candidate genes.
Subsequent, consecutive BBSRC grants, again aimed at explaining variation in lifetime cognitive ageing, studied the effects of single nucleotide polymorphisms (SNPs) from over 100 oxidative-stress-related genes, and conducted a genome-wide association study (GWAS). These latter two awards supported work on both LBC1921 and LBC1936. The principal aims of the CSO-funded waves 3 and 4 of the LBC1921 were to test the common cause hypothesis of cognitive ageing: i.e., they aimed to use the longitudinal data collected within old age to test the idea that agerelated physical and cognitive changes proceed in parallel, owing to shared causes.
The original aim of the LBC1936 study was to seek, "Determinants of normal cognitive ageing in survivors of the Scottish Mental Survey 1947," which was the title of the Research into Ageing grant that funded the wave 1 data collection. Those determinants of lifetime cognitive ageing were to include, "genetic, information processing, medical, economic, and psychosocial factors." Wave 2 of LBC1936 was intended, "to identify the mechanisms that cause white matter damage and how this Cohort profile: Lothian Birth Cohorts -6 causes cognitive decline with ageing". New to wave 2 was that the LBC1936 subjects underwent detailed structural magnetic resonance brain imaging (MRI).
From the beginning, the LBC1921 and LBC1936 studies were used to test hypotheses beyond those for which the core grant funding was obtained. Thus, the principal investigators, their research staff and students, and collaborators have used the two cohorts to test a wide range of possible contributors to cognitive changes across the lifespan and within old age, to study ageing and its casual factors more generally, and to address sundry topics for which the cohorts had relevant data.
Who is in the sample?
The Scottish Mental Survey 1932 took place simultaneously across schools in are summarised in Table 1 , with details of mean ages, numbers and sample composition.
Since recruitment and assessment at wave 1 (mean age 70), the LBC1936 participants have completed a 2 nd wave of follow-up at mean age 73. Between 2007 and 2010, 1062 participants were invited and 866 were assessed (448 men and 418 women). The majority of these undertook a detailed structural MRI brain scan at wave 3, and this is being repeated at wave 3. The LBC1936 are attending a 3 rd wave of assessment which commenced in 2011. The waves of assessment in the LBC1936 are summarised in Table 1 .
With regard to how attrition affects some key variables, the differences between returnees and non-returnees in the LBC1921 and LBC1936 are shown in Table 2 The LBC1936 brain imaging is performed in a separate clinic visit. Each wave also comprises a substantial set of questionnaires that are completed at home.
In the LBC1921, cognitive ability data were collected at all waves, including repeating the Moray House Test at waves 1 and 3 (previously completed at age 11 years). The cognitive battery consisted of a core set of psychometric tests, supplemented at subsequent waves by tests of processing speed. At each wave, medical history data were collected and updated, and a physical examination was conducted (wave 2 had a more limited physical assessment). At wave 2, LBC1921 participants additionally had retinal photographs taken, and facial photographs for asymmetry measurements. At wave 3, more detailed bodily measures were taken to assess fluctuating asymmetry. Blood samples were taken for DNA extraction and basic biochemistry and haematology (not wave 2). Latterly, biomarkers of inflammation and oxidative stress have been assessed (wave 3 in LBC1921). All cognitive and physical measures are to be repeated at the planned 4 th wave of data collection. Table 1 gives a summary of the LBC1921's assessments across the waves of testing.
The LBC1936 completed a much more detailed battery of psychometric cognitive tests, covering the domains of processing speed, memory, executive function, reasoning, and vocabulary. This was completed at waves 1 and 2. The Moray House test was also included at wave 1. A detailed medical history and physical examination was completed at both waves, and blood samples were taken for DNA extraction, basic biochemistry and haematology and, at wave 2, for assessments of markers of inflammation, oxidative stress, and blood-brain barrier integrity. At wave 2, the LBC1936 had retinal photographs taken, and underwent detailed magnetic resonance brain imaging and Doppler ultrasound scanning of the carotid arteries. All cognitive, physical and brain imaging assessments are being repeated at wave 3. Details of the measures completed at each wave are in Table 1 .
Both cohorts have completed self-report questionnaires at each wave. These have provided details of parental background, their children's education and occupation, and their own personality, well-being, social support, and activity participation (the latter 3 have been collected on more than 1 occasion).
What has it found? Key findings and publications
Between them, the LBC1921 and LBC1936 participants' data have appeared in over 100 peer-reviewed publications, so it is not possible to give more than an indicative summary here. Our book-A Lifetime of Intelligence-includes a summary and discussion of some of the studies published from the LBC1921 up to the end of 2007.
Given the unusual separation in time between the original intelligence test at age 11 and repeat testing in old age, a central contribution of the LBC studies has been to demonstrate that about half of the variance in cognitive ability is common to the measurements separated by seven decades. 1, 7 The studies have examined a wide range of variables to discover the determinants of lifetime cognitive change (the other half of the variation, if we ignore error of measurement for the moment), and the determinants of cognitive change and other aspects of well-being within old age.
An early contribution to cognitive ageing was to show-in the LBC1921-that possession of the e4 allele of the APOE gene was associated with intelligence at age 79 but not at age 11. 8 people with the e4 allele decreased in intelligence more than non-carriers across that 68-year period. APOE variation continues to influence cognitive ageing across the ninth decade; those individuals with the e4 allele declined more in non-verbal reasoning and verbal declarative memory from age 79 to age 87 than those without the e4 allele. 9 Both LBC studies have contributed to many candidate gene studies of cognitive ability and cognitive ageing. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Some of these putative associations-typical of candidate gene studies more generally-are failures to replicate. This is why we conducted a study with the LBC1936 sample in which many candidate genes for cognitive ageing were tested together, and few held up, though variants in COMT, KL, PRNP, PPP1R1B, SORL1 and WRN merited further study as possible contributors to cognitive ability and change. 21 The cohorts' data have also been used to examine gene systems with respect to cognitive ageing. In one study, over 100 genes associated with oxidative stress and cognition were examined, and an intronic SNP in the APP gene was possibly associated with cognitive ageing. 22 Investigation of Alzheimer disease genes, in addition to APOE, suggested that a Cohort profile: Lothian Birth Cohorts -12 haplotype from TRAPPC6A might be associated with non-verbal reasoning in nondemented older adults. 23 Studies of telomere length in the LBC samples provided limited evidence for association with cognitive or other age-related traits, 24, 25 with the possible exception of ischaemic heart disease. 26 The LBC comprised almost half of the participants used to conduct the first GWAS study of cognitive function in old age. 27 This did not find any SNPs that had genomewide significant associations with cognitive abilities. However, a gene-based test found that variation in the gene FNBP1L was associated significantly-at the genome-wide level-with fluid intelligence in old age. Furthermore, the study used a new method to estimate the 'relatedness' of unrelated subjects based on SNP similarity across 500,000+ SNPs. Using this information, it found that 40% of the variance in crystallised intelligence and 51% of that in fluid intelligence could be accounted for by unknown causal genetic variants in linkage disequilibrium with the tested SNPs. This was the first time that the heritability of cognitive traits had been estimated from DNA testing and not from twin or adoption studies.
Both LBC studies are available to take part in non-cognitive GWAS consortia, and already do so in studies of, for example, personality traits. 28, 29 Both LBC studies have also contributed to GWAS discoveries for several biomedical traits, including 68 genetic loci with new gene functions in platelet formation and megakaryopoiesis, 30 16 new genetic loci influencing lung function, 31 6 loci affecting mean arterial pressure 32 , and a new and strongest genetic influence (F3, coagulation factor III) for D-Dimer levels 33 . The LBC studies' data, alone, discovered three single nucleotide polymorphisms that accounted for 18% of the variance in activated partial inflammatory markers, 44 and body and facial symmetry. 45 The case of physical fitness is interesting. In the LBC1921, a fitness variable that was a linear combination of lung function (FEV 1 ), grip strength, and 6 metre walk time, accounted for over 3% of the variance in cognitive change between age 11 and age 79. 37 Also in the LBC1921, grip strength and non-verbal reasoning had cross-sectional associations at ages 79, 83, and 87; however, their age-related slopes were not correlated, and there was no evidence for any reciprocal dynamic influence over time. 46 Brain imaging-derived variables that have been studied and found to be associated with cognitive function in old age include white matter lesions, white matter integrity as assessed using diffusion tensor-and magnetisation transfer-derived variables, tractography-based white matter integrity, and brain iron deposition. 47 59 and childhood intelligence level. 60 The discovery of birth and placental weights and other birth data in some of the LBC1921 has produced some evidence of lifecourse continuity between these and brain white matter integrity in old age. 61 Two summary points may be made. Most putative predictors make small contributions to the variation in lifetime cognitive change: around 1 to 2% is typical.
Second, there is often reverse causation (or confounding), because we have found that associations between contemporaneously-assessed cognitive functions and putative determinants in old age are markedly attenuated-sometimes to below conventional statistical significance-after adjusting for childhood intelligence. To offer some different examples for the two cohorts, this occurred with apparent contributions from intellectual engagement, 59 C-reactive protein, 44 and brain iron deposits 51 : after adjustment for childhood intelligence, these contemporaneous associations with cognitive ability in old age were markedly attenuated or disappeared entirely.
Because there is such a wide range of phenotypic assessment in the LBC studies, they were always intended to be used to examine broader aspects of ageing than just the cognitive. Thus, they have been used to study outcomes such as personality and mood symptoms, 62, 63 processing speed as ageing biomarkers, 64 testing the hierarchical psychometric structure of cognitive abilities, 65 blood pressure, 66 renal function, 67 height and its association with cognitive ageing, 68 predictors of tooth loss in old age, how haematological profiles differ between men and women in old age, 70 lifetime and cross-generational social mobility, 71, 72 activities of daily living, 73 determinants of life satisfaction in old age, 74 and associations with other aspects of health and well-being in older people. 75 They have made contributions to validating cognitive instruments to estimate prior cognitive ability in dementia.
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What are the main strengths and weaknesses?
The main, unusual strength of both cohorts is the possession of a valid intelligence test score from age 11 years in people who are in old age, and who then took the same intelligence test as well as a host of other cognitive and other tests. This, with the detailed follow-up cognitive testing, means that almost life-long cognitive changes can be described and explained. A strength of the cohorts lies in being able to test for possible reverse causation between intelligence and putative determinants of cognitive ageing. It is also a strength that both LBC studies are narrow age cohorts, which means that the variables measured reflect differential ageing and not chronological age, which can otherwise swamp the variance in assessments and inflate effect sizes.
Both samples have genome-wide testing on over half a million SNPs, and the LBC1936 has a detailed structural brain imaging protocol, including diffusion tensor and magnetisation transfer imaging. Additional strengths are the wide variety of medical and psycho-social variables that are collected.
Weaknesses include the limited sample sizes of the two cohorts, and their being somewhat restricted in range with respect to childhood intelligence and childhood and adult socio-economic status. Can I get hold of the data? Where can I find out more?
The LBC study data have been the subject of many internal (within the University of Edinburgh) and external collaborations, which are encouraged. The LBC1921 study data have been made available to, and used by, the HALCyon collaboration.
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Those who have interests in outcomes other than cognitive domains are particularly Core cognitive and physical battery, repeat MR brain imaging.
Both Ongoing All participants are flagged with routine data sources providing deaths since wave 1, and, for LBC1936, morbidity data since wave 2. Note. For simplicity, the ages at waves 1, 2 and 3 in the LBC1921 are referred to as 79, 83 and 87 respectively. For the LBC1936, waves 1 and 2 are referred to as ages 70 and 73 respectively. 1 2.4 (0.7) 2.1 (0.7) Note. Values given are mean and standard deviation, except for sex and CVD, for the wave 1 sample (age 79 in LBC1921 and age 70 in LBC1936) split by returning status. For LBC1921, returnees refers to those participants who attended all 3 waves of assessment (at wave 3, some participants completed self-report questionnaires only). For LBC1936, returnees refers to the participants who attended waves 1 and 2. IQ calculated from Moray House Test score corrected for age in days at time of testing and converted to IQ scale. MMSE = Mini-Mental State
